Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs-Reference-Cited by-同舟云学术

Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs

Published:2017-03-20 Issue:4 Volume:37 Page:429-437
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Hansen Richard A.¹,Qian Jingjing¹,Berg Richard²,Linneman James²,Seoane-Vazquez Enrique³,Dutcher Sarah K.⁴,Raofi Saeid⁴,Page C. David⁵⁶,Peissig Peggy²

Affiliation:

1. Department of Health Outcomes Research and Policy; Auburn University, Harrison School of Pharmacy; Auburn Alabama

2. Marshfield Clinic Research Foundation; Biomedical Informatics Research Center; Marshfield Wisconsin

3. Massachusetts College of Pharmacy and Health Sciences; International Center for Pharmaceutical Economics and Policy; Boston Massachusetts

4. U.S. Food and Drug Administration; Office of Generic Drugs; Silver Spring Maryland

5. Department of Biostatistics and Medical Informatics; University of Wisconsin School of Medicine and Public Health; Madison Wisconsin

6. Department of Computer Science; University of Wisconsin School of Medicine and Public Health; Madison Wisconsin

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Pharmacology (medical)

Reference26 articles.

1. Generic Pharmaceutical Association Generic drug savings in the U.S. - Fifth Annual Edition 2013 http://www.gphaonline.org/media/cms/2013_Savings_Study_12.19.2013_FINAL.pdf

2. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues;Crawford;Seizure,2006

3. Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers;Del Tacca;Br J Clin Pharmacol,2009

4. Generic substitution in the treatment of epilepsy: patient and physician perceptions;Berg;Epilepsy Behav,2008

5. Perceptions of and barriers to use of generic medications in a rural African American population, Alabama, 2011;Sewell;Prev Chronic Dis,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Authorized Generics In The US: Prevalence, Characteristics, And Timing, 2010–19;Health Affairs;2023-08-01

2. Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar;Therapeutic Advances in Gastroenterology;2023-01

3. Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study;Frontiers in Pharmacology;2022-10-07

4. Understanding treatment patterns and patient-reported outcomes associated with the use of authorized generics and corresponding independent generics across multiple therapeutic areas;Current Medical Research and Opinion;2022-04-08

5. Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization;ClinicoEconomics and Outcomes Research;2022-04